Prosecution Insights
Last updated: October 25, 2026
Application No. 19/232,595

STENT FOR END-TO-END ANASTOMOSIS

Non-Final OA §112
Filed
Jun 09, 2025
Priority
Jan 10, 2020 — CIP of 11/974,748 +4 more
Examiner
OU, JING RUI
Art Unit
3771
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Connex Biomedical Inc.
OA Round
1 (Non-Final)
54%
Grant Probability
Moderate
1-2
OA Rounds
2y 11m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 54% of resolved cases
54%
Career Allowance Rate
425 granted / 795 resolved
-16.5% vs TC avg
Strong +52% interview lift
Without
With
+51.6%
Interview Lift
resolved cases with interview
Typical timeline
4y 3m
Avg Prosecution
50 currently pending
Career history
838
Total Applications
across all art units

Statute-Specific Performance

§101
0.9%
-39.1% vs TC avg
§103
42.8%
+2.8% vs TC avg
§102
24.0%
-16.0% vs TC avg
§112
26.6%
-13.4% vs TC avg
Black line = Tech Center average estimate • Based on career data from 795 resolved cases

Office Action

§112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . This action is in response to the non-provisional application filed on 06/09/2025. Claims 1-20 are pending. Claims 1 and 16 are independent. Claim Objections Claim 5 is objected to because of the following informalities: Claim 5, line 1-2, “a plurality of undulating connection member connecting” should be amended to --a plurality of undulating connection members each connecting--. Appropriate correction is required. Claim Interpretation The following is a quotation of 35 U.S.C. 112(f): (f) Element in Claim for a Combination. – An element in a claim for a combination may be expressed as a means or step for performing a specified function without the recital of structure, material, or acts in support thereof, and such claim shall be construed to cover the corresponding structure, material, or acts described in the specification and equivalents thereof. The following is a quotation of pre-AIA 35 U.S.C. 112, sixth paragraph: An element in a claim for a combination may be expressed as a means or step for performing a specified function without the recital of structure, material, or acts in support thereof, and such claim shall be construed to cover the corresponding structure, material, or acts described in the specification and equivalents thereof. The claims in this application are given their broadest reasonable interpretation using the plain meaning of the claim language in light of the specification as it would be understood by one of ordinary skill in the art. The broadest reasonable interpretation of a claim element (also commonly referred to as a claim limitation) is limited by the description in the specification when 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, is invoked. As explained in MPEP § 2181, subsection I, claim limitations that meet the following three-prong test will be interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph: (A) the claim limitation uses the term “means” or “step” or a term used as a substitute for “means” that is a generic placeholder (also called a nonce term or a non-structural term having no specific structural meaning) for performing the claimed function; (B) the term “means” or “step” or the generic placeholder is modified by functional language, typically, but not always linked by the transition word “for” (e.g., “means for”) or another linking word or phrase, such as “configured to” or “so that”; and (C) the term “means” or “step” or the generic placeholder is not modified by sufficient structure, material, or acts for performing the claimed function. Use of the word “means” (or “step”) in a claim with functional language creates a rebuttable presumption that the claim limitation is to be treated in accordance with 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph. The presumption that the claim limitation is interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, is rebutted when the claim limitation recites sufficient structure, material, or acts to entirely perform the recited function. Absence of the word “means” (or “step”) in a claim creates a rebuttable presumption that the claim limitation is not to be treated in accordance with 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph. The presumption that the claim limitation is not interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, is rebutted when the claim limitation recites function without reciting sufficient structure, material or acts to entirely perform the recited function. Claim limitations in this application that use the word “means” (or “step”) are being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, except as otherwise indicated in an Office action. Conversely, claim limitations in this application that do not use the word “means” (or “step”) are not being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, except as otherwise indicated in an Office action. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 1-20 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Claim 1 recites that limitation “the proximal tubular section comprising a proximal end section configured to occlude a central lumen of the tissue connection stent when the proximal tubular section and the distal flange section are in the second diametrically expanded state.” As described in the specification, the second diametrically expanded state is shown in Figs 3B, 4B, and 5B. It is unclear how the proximal end section is configured to occlude a central lumen of the tissue connection stent when the proximal tubular section and the distal flange section are in the second diametrically expanded state (open, expanded state). Therefore, the claim is indefinite. Claims 2-15 are rejected because they depend on claim 1. Claim 5 recites the limitation “a plurality of undulating connection member connecting an apex of the plurality of second strut members (18a, Fig. 1) with an apex of the plurality of the first strut members (18b, Fig. 1).” However, as described in the specification, the plurality of undulating connection members (26, Fig. 1) are not connecting an apex of the plurality of second strut members with an apex of the plurality of the first strut members. Instead, the plurality of undulating connection members (26, Fig. 1) each connects an apex of the plurality of first strut members (18a, Fig. 1) and an apex of a plurality of third struts members (24, Fig. 1) Claim 16 recites that limitation “the proximal tubular section comprising a proximal end section configured to occlude a central lumen of the tissue connection stent when the proximal tubular section and the distal flange section are in the second diametrically expanded state.” As described in the specification, the second diametrically expanded state is shown in Figs 3B, 4B, and 5B. It is unclear how the proximal end section is configured to occlude a central lumen of the tissue connection stent when the proximal tubular section and the distal flange section are in the second diametrically expanded state (open, expanded state). Therefore, the claim is indefinite. Claims 17-20 are rejected because they depend on claim 16. Conclusion The prior art made of record and not relied upon is considered pertinent to applicant's disclosure. US 10441416 B2 Oba; Travis Zenyo et al. discloses a prosthetic heart valve having a stent frame having a proximal tubular section and a distal flange section. US 10610362 B2 Quadri; Arshad et al. discloses a prosthetic heart valve having a stent frame having a proximal tubular section and a distal flange section. US 20050049678 A1 Cocks, Graeme et al. discloses a stent frame having a proximal tubular section and a distal flange section. US 20200046525 A1 Kónya; András et al. discloses a stent frame having a proximal tubular section and a distal flange section. US 20230329855 A1 Banas; Christopher E. et al. discloses an anastomosis device comprising a stent frame having a proximal tubular section and a distal flange section. Any inquiry concerning this communication or earlier communications from the examiner should be directed to JING RUI OU whose telephone number is (571)270-5036. The examiner can normally be reached M-F 9:00am -5:00pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Jackie Ho can be reached at (571) 272-4696. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /JING RUI OU/Primary Examiner, Art Unit 3771
Read full office action

Prosecution Timeline

Jun 09, 2025
Application Filed
Oct 16, 2026
Non-Final Rejection mailed — §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12758228
IMPLANTABLE EMBOLIZATION DEVICE
4y 3m to grant Granted Oct 13, 2026
Patent 12740879
MODULAR HANDLE COMPRISING A TRIGGER WIRE ACTUATION MECHANISM FOR A PROSTHESIS DELIVERY DEVICE
2y 3m to grant Granted Sep 22, 2026
Patent 12733919
Wound Closure and Tissue Coupling Systems and Methods
3y 8m to grant Granted Sep 15, 2026
Patent 12727887
ANASTOMOSIS DEVICE, SYSTEMS, AND METHODS
4y 4m to grant Granted Sep 08, 2026
Patent 12708537
DELIVERY SYSTEM AID AND ASSOCIATED SYSTEMS AND METHODS
6y 0m to grant Granted Aug 18, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
54%
Grant Probability
99%
With Interview (+51.6%)
4y 3m (~2y 11m remaining)
Median Time to Grant
Low
PTA Risk
Based on 795 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month